The Hematologic Malignancies Conference
The Hematologic Malignancies Conference
批准号:
10752784
负责人:
Alejandro Gutierrez
金额:
$3.89万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-08-01 至 2024-07-31
关键词:
AddressAgingAmericanBiochemistryBiologyCellsCellular biologyCollaborationsCommunitiesCreativenessDedicationsDevelopmentDevelopmental Therapeutics ProgramDiseaseEducational workshopEnsureEnvironmentEpigenetic ProcessEquilibriumFeedbackFosteringFutureGene ExpressionGenerationsGeneticGoalsHematologic NeoplasmsHematological DiseaseHematopoiesisHematopoieticHematopoietic stem cellsHousingImmuneIndividualInflammationInternationalInterpersonal RelationsLightingLightningMalignant - descriptorMentorsMetabolismMolecularOralPharmaceutical ChemistryPostdoctoral FellowProductivityRegulationRelaxationRequest for ProposalsResearchResearch PersonnelScienceScientistSocietiesTalentsTechniquesTimeUnderrepresented MinorityWomanWorkcareercareer developmentcatalystcostdesigneducational atmospheregraduate studenthematopoietic differentiationinnovationinterestlecturesmeetingsnext generationnovelnovel therapeutic interventionpeerpostersprofessorprogramsstem cell biologysymposiumtherapeutic targettumortumorigenesis
中文摘要
摘要/摘要
这个R13应用的目标是为2023年科学研究会议提供部分支持
美国实验生物学学会联合会管理的恶性血液病
(FASE B)。这一年两次的会议是该领域的首要会议,并提供了宝贵的机会
职业生涯早期的科学家与同行互动,并在高度合作的情况下领导该领域的知名研究人员
和亲密的环境。许多该领域的知名调查人员看到他们出席了这次会议
当他们作为实习生时,对他们的职业发展和帮助催化职业生涯的能力至关重要
培养年轻的研究人员是吸引老牌科学家参加这次会议的主要原因。《临时报》
科学节目突出了血液学不同子领域中最令人兴奋的科学
科学界非常感兴趣的恶性肿瘤。主要主题包括:1)恶性造血干细胞
细胞生物学,2)正常的造血发育,3)克隆的造血和衰老,4)炎症和
造血,5)造血生态位,6)白血病基因表达程序的调节,6)
代谢和表观遗传学,以及7)新的治疗策略。来自国际的两场主旨演讲
该领域公认的领导者主持了这次会议。许多演示文稿槽都是专门设置的
向初级调查人员口头陈述,从摘要中挑选。海报照明弹提供了
让学员有机会在口头上向观众介绍他们的作品,并确保海报
会议是会议最具互动性的部分之一。本R13中唯一的预算请求
申请获得50%的注册费和所有学员(研究生和
博士后),他们将在这次会议上发表口头或海报演讲。
英文摘要
SUMMARY/ABSTRACT
The goal of this R13 application is to provide partial support to the 2023 Scientific Research Conference on
Hematologic Malignancies administered by the Federation of American Societies for Experimental Biology
(FASEB). This biannual conference is the premier meeting in the field, and provides invaluable opportunities for
early-career scientists to interact with peers and leading established investigators in the field in a highly collegial
and intimate setting. Numerous established investigators in the field see their attendance at this conference
when they were trainees as pivotal to their career development, and the ability to help catalyze the career
development of young investigators is a major draw for established scientists to this conference. The provisional
scientific program highlights the most exciting science at the cutting edge of diverse sub-fields of hematologic
malignancies of deep interest to the scientific community. Major topics include 1) malignant hematopoietic stem
cell biology, 2) normal hematopoietic development, 3) clonal hematopoiesis and aging, 4) inflammation and
hematopoiesis, 5) the hematopoietic niche, 6) regulation of leukemogenic gene expression programs, 6)
metabolism and epigenetics, and 7) novel therapeutic strategies. Two keynote lectures from internationally
recognized leaders in the field bookend the conference. A number of presentation slots are specifically dedicated
to oral presentations by to junior investigators to be selected from abstracts. Poster Lighting Rounds provide an
opportunity for trainees to introduce the audience to their work during oral sessions, and ensure that the poster
sessions are one of the most interactive parts of the conference. The sole budgetary request in this R13
application is for 50% support of the registration and housing costs for all trainees (graduate students and
postdoctoral fellows) who will present oral or poster presentations at this conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
-
批准号:10415133
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
-
批准号:9981054
-
项目类别:
-
资助金额:$45.39万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
-
批准号:10172856
-
项目类别:
-
资助金额:$45.05万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
-
批准号:9116144
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
-
批准号:10643715
-
项目类别:
-
资助金额:$43.37万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
-
批准号:9763509
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2015
-
负责人:Alejandro Gutierrez
-
依托单位:
Discovery and Targeting of Apoptosis Resistance Mechanisms in High-Risk T-ALL
-
批准号:8471673
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2012
-
负责人:Alejandro Gutierrez
-
依托单位:
Discovery and Targeting of Apoptosis Resistance Mechanisms in High-Risk T-ALL
-
批准号:8288545
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2012
-
负责人:Alejandro Gutierrez
-
依托单位:
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
-
批准号:7864277
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2008
-
负责人:Alejandro Gutierrez
-
依托单位:
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
-
批准号:8104193
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2008
-
负责人:Alejandro Gutierrez
-
依托单位:
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
-
批准号:7628345
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2008
-
负责人:Alejandro Gutierrez
-
依托单位:
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
-
批准号:8292154
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2008
-
负责人:Alejandro Gutierrez
-
依托单位:
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
-
批准号:7449856
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2008
-
负责人:Alejandro Gutierrez
-
依托单位:
海外基金